Abstract
A review of the literature relating hepatic abnormalities with the giant cell arteritis, polymyalgia rheumatica syndrome is presented. A case of polymyalgia rheumatica with biochemical and histological abnormalities of the liver is described. It is suggested that a more detailed investigation of liver function should be made in patients with this syndrome where reasonably indicated.
Full text
PDF
Images in this article
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Dickson E. R., Maldonado J. E., Sheps S. G., Cain J. A., Jr Systemic giant-cell arteritis with polymyalgia rheumatica, reversible abnormalities of liver function. JAMA. 1973 Jun 11;224(11):1496–1498. [PubMed] [Google Scholar]
- Glick E. N. Raised serum-alkaline-phosphatase levels in polymyalgia rheumatica. Lancet. 1972 Aug 12;2(7772):328–328. doi: 10.1016/s0140-6736(72)92932-7. [DOI] [PubMed] [Google Scholar]
- Hall G. H., Hargreaves T. Giant-cell arteritis and raised serum-alkaline-phosphatase levels. Lancet. 1972 Jul 1;2(7766):48–48. doi: 10.1016/s0140-6736(72)91310-4. [DOI] [PubMed] [Google Scholar]
- Hilton A. M., Boyes B. E., Smith P. J., Sharp J., Dymock I. W. Liver disease in patients with joint symptoms. Ann Rheum Dis. 1974 Nov;33(6):540–547. doi: 10.1136/ard.33.6.540. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Long R., James O. Polymyalgia rheumatica and liver disease. Lancet. 1974 Jan 19;1(7847):77–79. doi: 10.1016/s0140-6736(74)92292-2. [DOI] [PubMed] [Google Scholar]